Steven L. Hoerter - Mar 21, 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Mar 21, 2022
Transactions value $
-$28,697
Form type
4
Date filed
3/23/2022, 04:15 PM
Previous filing
Jan 20, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Tax liability -$28.7K -3.15K -7.74% $9.11 37.5K Mar 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 18, 2019, the Reporting Person was granted 30,000 Restricted Stock Units ("RSUs") which vest in four (4) equal annual installments beginning on March 18, 2020. These RSUs were reported in Table I on a Form 4 filed on March 20, 2019. The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021 to cover tax obligations.